Magnetic resonance angiography of the kidney

Seminars in Nephrology

Volumn 20, Issue 5, 2000, Pages 450-455

  Marcos, H B ^a   Choyke, P L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; GADOLINIUM CHELATE;

ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; BOLUS INJECTION; CASE REPORT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY SIZE; LABORATORY DIAGNOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; RENOGRAPHY; RENOVASCULAR HYPERTENSION;

CONTRAST MEDIA; FIBROMUSCULAR DYSPLASIA; GADOLINIUM; HUMANS; HYPERTENSION, RENOVASCULAR; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; RENAL ARTERY OBSTRUCTION; SENSITIVITY AND SPECIFICITY;

EID: 0033821702     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abdominal aorta and renal artery stenosis: Evaluation with MR angiography
2. Imaging of the renal arteries: Value of MR angiography
3. Time of flight renal MR angiography: Utility in patients with renal insufficiency
4. Magnetic resonance imaging: A reliable test for the evaluation of proximal atherosclerotic renal arterial stenosis
5. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography
6. Three-dimensional gadolinium-enhanced MR angiography for aortoiliac inflow assessment plus renal artery screening in a single breath hold
7. Renal MR angiography: A comprehensive approach
8. Breath-hold, contrast-enhanced, three-dimensional MR angiography
9. Renal arteries: Optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold
10. Contrast-enhanced abdominal MR angiography: Optimization of imaging delay time by automating the detection of contrast material arrival in the aorta
11. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: Application to the renal arteries
12. Renal artery stenosis: Evaluation with conventional angiography versus gadolinium-enhanced MR angiography
13. Evaluation of the aortoiliac and renal arteries: Comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography
14. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector
15. Renal artery stenosis: Evaluation with breath-hold, three-dimensional, dynamic, gadolinium-enhanced versus three-dimensional, phase-contrast MR angiography
16. Renal artery stenosis: Grading of hemodynamic changes with cine phase-contrast MR blood flow measurements
17. Detection of main renal artery stenosis using phase-contrast cine MR angiography
18. Apparent prevalence of curable hypertension in the hypertension detection and follow-up program
19. Renal anatomic changes on magnetic resonance imaging and gadolinium-enhanced magnetic resonance angiography after renal revascularization
20. Nephrotoxicity of high-dose gadolinium compared to iodinated contrast
21. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features
22. Diagnosis of renal artery stenosis: Feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate
23. Diagnosis of renovascular hypertension: Feasibility of captopril-sensitized dynamic MR imaging and comparison with captopril scintigraphy
24. MR angiography of renal artery stenosis: Value of the combination of three-dimensional time-of-flight and three-dimensional phase-contrast MR angiography sequences
25. Hemodynamic significance of renal artery stenosis: Digital subtraction angiography versus systolically gated three-dimensional phase-contrast MR angiography
26. Renal artery disease in the elderly
27. Asymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine
28. Arterial fibromuscular dysplasia